Global AI Inc. (OTC:GLAI) Expands AI Solutions into Pharmaceuticals

New York, January 29, 2026 — Leads & Copy — Global AI Inc. (OTC: GLAI) has secured a contract with a major pharmaceutical and life sciences company to implement its AI-driven solutions for automating compliance and HR workflows.

Global AI will deploy its Agentic AI Platform to support regulatory monitoring, compliance reporting, and internal human resources operations.

The agreement highlights Global AI’s capability to deliver AI-driven automation solutions within highly regulated enterprise environments.

The platform’s compliance automation capabilities ensure full auditability and governance throughout the reporting lifecycle, meeting enterprise and regulatory standards for global pharmaceutical organizations.

Darko Horvat, Chairman and CEO of Global AI, said the deployment demonstrates enterprise-scale capability and builds credibility within the pharmaceutical industry. Horvat believes this will encourage broader adoption of the company’s AI product suite.

Global AI’s Agentic AI platform allows organizations to design, deploy, and scale AI workflows with built-in governance and compliance.

The company aims to provide secure, high-performance AI products that improve decision-making, accelerate transformation, and increase shareholder value.

Source: Global AI

×

Welcome!

AIReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily AI Story Leads via email 10:30 am ET Mon-Fri.